Antibiotic use before chlamydia and gonorrhea genital and extragenital screening in the sexually transmitted infection clinical setting

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 1, 2015, Pages 121-128

  Dukers Muijrers, Nicole H T M ^a,b   Van Liere, Genevieve A F S ^a,b   Wolffs, Petra F G ^b   Heijer, Casper Den ^a   Werner, Marita I L S ^a   Hoebea, Christian J P A ^a,b  

^a South Limburg Public Health Service   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; MACROLIDE; NITROFURANTOIN; OFLOXACIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONSULTATION; CONTROLLED STUDY; DRUG USE; FEMALE; GONORRHEA; HETEROSEXUAL MALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; NEISSERIA GONORRHOEAE; PREVALENCE; SCREENING; SEXUAL ORIENTATION; ANAL CANAL; CHLAMYDIA INFECTIONS; FEMALE UROGENITAL DISEASES; ISOLATION AND PURIFICATION; MALE UROGENITAL DISEASES; MICROBIOLOGY; MIDDLE AGED; OROPHARYNX; YOUNG ADULT;

ADULT; ANAL CANAL; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; FEMALE UROGENITAL DISEASES; GONORRHEA; HUMANS; MACROLIDES; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; NEISSERIA GONORRHOEAE; OROPHARYNX; PENICILLINS; TETRACYCLINES; YOUNG ADULT;

EID: 84920166060     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03932-14     Document Type: Article

References (23)

1. Turner CF, Rogers SM, Miller HG, Miller WC, Gribble JN, Chromy JR, Leone PA, Cooley PC, Quinn TC, Zenilman JM. 2002. Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA 287:726-733. http://dx.doi.org/10.1001/jama.287.6.726.
2. Senior K. 2012. Chlamydia: a much underestimated STI. Lancet Infect Dis 12:517-518. http://dx.doi.org/10.1016/S1473-3099(12)70161-5.
3. Davies SC, Fowler T, Watson J, Livermore DM, Walker D. 2013. Annual report of the Chief Medical Officer: infection and the rise of antimicrobial resistance. Lancet 381:1606-1609. http://dx.doi.org/10.1016 /S0140-6736(13)60604-2.
4. World Health Organization. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. World Health Organization, Geneva, Switzerland.
5. Low N, Unemo M, Skov Jensen J, Breuer J, Stephenson J. 2014. Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea. PLoS Med 11: e1001598. http://dx.doi.org/10.1371/journal.pmed.1001598.
6. Price MJ, Ades AE, De Angelis D, Welton NJ, Macleod J, Soldan K, Simms I, Turner K, Horner PJ. 2013. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol 178:484-492. http://dx.doi .org/10.1093/aje/kws583.
7. Centers for Disease Control and Prevention. 2010. STD treatment guidelines. MMWR Recomm Rep 59:45.
8. British Association for Sexual Health and HIV. 2010. Chlamydia trachomatis UK testing guidelines. British Association for Sexual Health and HIV, Macclesfield, Cheshire, England. http://www.bashh.org/documents /3352.pdf.
9. Westrom L. 1980. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.AmJ Obstet Gynecol 138:880-892.
10. O'Rourke KM, Fairley CK, Samaranayake A, Collignon P, Hocking JS. 2009. Trends in Chlamydia positivity over time among women in Melbourne Australia, 2003 to 2007. Sex Transm Dis 36:763-767. http://dx.doi .org/10.1097/OLQ.0b013e3181b12765.
11. Ginige S, Chen MY, Hocking JS, Read TR, Fairley CK. 2006. Antibiotic consumption and chlamydia prevalence in international studies. Sex Health 3:221-224. http://dx.doi.org/10.1071/SH06013.
12. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H, ESAC Project Group. 2006. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 58:401-407. http://dx.doi.org/10.1093 /jac/dkl188.
13. European Centre for Disease Prevention and Control. 2014. Surveillance of antimicrobial consumption in Europe 2011. ECDC, Stockholm, Sweden.
14. Land JA, Van Bergen JE, Morré SA, Postma MJ. 2010. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update 16:189-204. http://dx.doi.org/10.1093 /humupd/dmp035.
15. Walker J, Tabrizi SN, Fairley CK, Chen MY, Bradshaw CS, Twin J, Taylor N, Donovan B, Kaldor JM, McNamee K, Urban E, Walker S, Currie M, Birden H, Bowden F, Gunn J, Pirotta M, Gurrin L, Harindra V, Garland SM, Hocking JS. 2012. Chlamydia trachomatis incidence and re-infection among young women-behavioural and microbiological characteristics. PLoS One 7:e37778. http://dx.doi.org/10.1371/journal .pone.0037778.
16. Chen MY, Fairley CK, De Guingand D, Hocking J, Tabrizi S, Wallace EM, Grover S, Gurrin L, Carter R, Pirotta M, Garland S. 2009. Screening pregnant women for chlamydia: what are the predictors of infection? Sex Transm Infect 85:31-35. http://dx.doi.org/10.1136/sti.2008.030700.
17. Chen MY, Rohrsheim R, Donovan B. 2007. The differing profiles of symptomatic and asymptomatic Chlamydia trachomatis-infected men in a clinical setting. Int J STD AIDS 18:384-388. http://dx.doi.org/10.1258 /095646207781024810.
18. Klausner JD, Aplasca MR, Mesola VP, Bolan G, Whittington WL, Holmes KK. 1999 Correlates of gonococcal infection and of antimicrobi-al-resistant Neisseria gonorrhoeae among female sex workers, Republic of the Philippines, 1996-1997. J Infect Dis 179:729-733.
19. Dukers-Muijrers NH, Speksnijder AG, Morre SA, Wolffs PF, van der Sande MA, Brink AA, van den Broek IV, Werner MI, Hoebe CJ. 2013. Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms. PLoS One 14:e81236. http://dx.doi.org/10.1371/journal.pone .0081236.
20. Hathorn E, Opie C, Goold P. 2012. What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women? Sex Transm Infect 88: 352e354. http://dx.doi.org/10.1136 /sextrans-2011-050466.
21. European Centre for Disease Prevention and Control. 2012. Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe. ECDC, Stockholm, Sweden.
22. National Institute for Public Health and the Environment. 2014. Sexually transmitted infections, including HIV, in The Netherlands, 2013. Report number 150002005/2014. National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
23. Stokholm J, Schjørring S, Eskildsen CE, Pedersen L, Bischoff AL, Følsgaard N, Carson CG, Chawes BL, Bønnelykke K, Mølgaard A, Jacobsson B, Krogfelt KA, Bisgaard H. 2014. Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect 20:629-635. http://dx.doi.org/10.1111/1469-0691.12411.